STOCK TITAN

Vigil Neuroscience to Present at 2022 Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vigil Neuroscience, Inc. (Nasdaq: VIGL) has announced that CEO Ivana Magovčević-Liebisch, Ph.D., J.D., will speak at the 2022 Jefferies Global Healthcare Conference on June 8, 2022, at 2:00 p.m. ET in New York City. The event will focus on the company's commitment to leveraging microglia to develop therapies for neurodegenerative diseases. A live webcast of the discussion can be accessed through the 'Investors' section of their website, with an archived replay available for 90 days post-event.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that Ivana Magovčević-Liebisch Ph.D., J.D., President and Chief Executive Officer of Vigil, will participate in a fireside chat at the 2022 Jefferies Global Healthcare Conference on Wednesday, June 8, 2022 at 2:00 p.m. ET in New York, New York.

To access a live webcast of this presentation, please visit “Events & Presentations” in the “Investors” section of the Vigil website at www.vigilneuro.com. An archived replay will be available there for approximately 90 days following the presentation.

About Vigil Neuroscience
Vigil Neuroscience is a microglia-focused therapeutics company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in our efforts to develop precision-based therapies to improve the lives of patients and their families.

Internet Posting of Information
Vigil Neuroscience routinely posts information that may be important to investors in the 'Investors' section of its website at https://www.vigilneuro.com. The company encourages investors and potential investors to consult our website regularly for important information about Vigil Neuroscience.


FAQ

When will Vigil Neuroscience participate in the Jefferies Global Healthcare Conference?

Vigil Neuroscience will participate in the Jefferies Global Healthcare Conference on June 8, 2022.

Who is representing Vigil Neuroscience at the conference?

Ivana Magovčević-Liebisch, Ph.D., J.D., the CEO, will represent Vigil Neuroscience.

What time is Vigil's presentation at the Jefferies Conference?

The presentation is scheduled for 2:00 p.m. ET.

How can I access the Vigil Neuroscience webcast?

The webcast can be accessed via the 'Events & Presentations' section on Vigil's website.

How long will the archived replay of the presentation be available?

The archived replay will be available for approximately 90 days after the presentation.

Vigil Neuroscience, Inc.

NASDAQ:VIGL

VIGL Rankings

VIGL Latest News

VIGL Stock Data

69.09M
31.99M
21.27%
80.16%
1.29%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
WATERTOWN